The agency told Bayer it needs additional time to review the non-hormonal drug, called elinzanetant. Regulators in Canada and the U.K. have already cleared it for use.

Julia Zumpano, RD, LD, has been a registered dietician at the Cleveland Clinic Center for Human Nutrition for almost 20 years, specializing in disease prevention and management. Highlights ...

The FDA may remove the warning labels on hormone replacement therapies used to treat the symptoms of menopause. Doctors say ...

Yale New Haven Hospital will no longer provide gender-affirming medication treatments for patients under 19, after ...